Release Date: Nov 2017
CC: PC, PBL, SBP
Susan E. Sharp, PhD
Director of Microbiology, Kaiser Permanente, Portland, OR; Associate Professor of Pathology, Oregon Health and Sciences University, Portland, OR
The clinical microbiology laboratory has seen a number of significant changes in the way we perform our testing over the last 10 years. There are more and more of these changes to come. Microbiology laboratories will continue to expand into the areas of proteomics, genomics, next generation sequencing, and rapid phenotypic testing as we go forward. New ways of diagnosing infectious diseases are at hand and will continue to develop rapidly over the next 5 to 10 years and we must be ready to adapt and change to this new environment. This session will take a look at where we have been, where we are now, and where we might possibly go in the future with infectious disease diagnosis using sepsis as one example.
After attending this session, participants will be able to:
· Visualize the possible microbiology laboratory of the future.
· Discuss the impact that genomics and proteomics have had and will continue to have in clinical microbiology.
· Develop ways for the laboratory to achieve effective patient care in a changing world of infectious disease diagnostics.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians, Students